nodes	percent_of_prediction	percent_of_DWPC	metapath
Sertraline—SIGMAR1—Progesterone—uterine cancer	0.256	0.379	CbGbCtD
Sertraline—CYP2C9—Medroxyprogesterone Acetate—uterine cancer	0.0551	0.0818	CbGbCtD
Sertraline—CYP2C19—Progesterone—uterine cancer	0.0439	0.0652	CbGbCtD
Sertraline—CYP1A2—Progesterone—uterine cancer	0.0405	0.0601	CbGbCtD
Sertraline—CYP2C9—Progesterone—uterine cancer	0.0365	0.0542	CbGbCtD
Sertraline—ABCB1—Progesterone—uterine cancer	0.0354	0.0526	CbGbCtD
Sertraline—CYP2D6—Progesterone—uterine cancer	0.0334	0.0495	CbGbCtD
Sertraline—CYP3A4—Medroxyprogesterone Acetate—uterine cancer	0.032	0.0475	CbGbCtD
Sertraline—ABCB1—Dactinomycin—uterine cancer	0.0281	0.0417	CbGbCtD
Sertraline—CYP3A4—Progesterone—uterine cancer	0.0212	0.0315	CbGbCtD
Sertraline—CYP2B6—Doxorubicin—uterine cancer	0.0211	0.0313	CbGbCtD
Sertraline—CYP1A2—Etoposide—uterine cancer	0.0181	0.0269	CbGbCtD
Sertraline—ABCB1—Etoposide—uterine cancer	0.0158	0.0235	CbGbCtD
Sertraline—ABCB1—Doxorubicin—uterine cancer	0.0108	0.016	CbGbCtD
Sertraline—CYP2D6—Doxorubicin—uterine cancer	0.0102	0.0151	CbGbCtD
Sertraline—CYP3A4—Etoposide—uterine cancer	0.00949	0.0141	CbGbCtD
Sertraline—CYP3A4—Doxorubicin—uterine cancer	0.00648	0.00961	CbGbCtD
Sertraline—SIGMAR1—Levonorgestrel—Progesterone—uterine cancer	0.00287	1	CbGdCrCtD
Sertraline—SIGMAR1—myometrium—uterine cancer	0.00128	0.0351	CbGeAlD
Sertraline—MAOB—myometrium—uterine cancer	0.00122	0.0336	CbGeAlD
Sertraline—MAOA—myometrium—uterine cancer	0.00104	0.0286	CbGeAlD
Sertraline—SIGMAR1—uterine cervix—uterine cancer	0.000995	0.0273	CbGeAlD
Sertraline—SIGMAR1—smooth muscle tissue—uterine cancer	0.000967	0.0265	CbGeAlD
Sertraline—MAOB—uterine cervix—uterine cancer	0.000952	0.0261	CbGeAlD
Sertraline—SIGMAR1—decidua—uterine cancer	0.000948	0.026	CbGeAlD
Sertraline—MAOB—decidua—uterine cancer	0.000907	0.0249	CbGeAlD
Sertraline—SIGMAR1—endometrium—uterine cancer	0.0009	0.0247	CbGeAlD
Sertraline—MAOB—renal system—uterine cancer	0.000891	0.0244	CbGeAlD
Sertraline—SIGMAR1—mammalian vulva—uterine cancer	0.00087	0.0239	CbGeAlD
Sertraline—MAOB—endometrium—uterine cancer	0.000861	0.0236	CbGeAlD
Sertraline—SLC6A2—decidua—uterine cancer	0.00084	0.023	CbGeAlD
Sertraline—MAOB—mammalian vulva—uterine cancer	0.000833	0.0229	CbGeAlD
Sertraline—SIGMAR1—uterus—uterine cancer	0.000829	0.0227	CbGeAlD
Sertraline—MAOA—uterine cervix—uterine cancer	0.000812	0.0223	CbGeAlD
Sertraline—MAOB—uterus—uterine cancer	0.000794	0.0218	CbGeAlD
Sertraline—MAOA—decidua—uterine cancer	0.000774	0.0212	CbGeAlD
Sertraline—MAOA—renal system—uterine cancer	0.00076	0.0208	CbGeAlD
Sertraline—SLC6A4—female reproductive system—uterine cancer	0.00075	0.0206	CbGeAlD
Sertraline—MAOA—endometrium—uterine cancer	0.000735	0.0202	CbGeAlD
Sertraline—MAOB—female reproductive system—uterine cancer	0.000713	0.0196	CbGeAlD
Sertraline—MAOA—mammalian vulva—uterine cancer	0.000711	0.0195	CbGeAlD
Sertraline—SIGMAR1—female gonad—uterine cancer	0.000678	0.0186	CbGeAlD
Sertraline—MAOA—uterus—uterine cancer	0.000677	0.0186	CbGeAlD
Sertraline—SIGMAR1—vagina—uterine cancer	0.000674	0.0185	CbGeAlD
Sertraline—SLC6A2—female reproductive system—uterine cancer	0.000661	0.0181	CbGeAlD
Sertraline—MAOB—female gonad—uterine cancer	0.000649	0.0178	CbGeAlD
Sertraline—MAOB—vagina—uterine cancer	0.000645	0.0177	CbGeAlD
Sertraline—CYP1A2—renal system—uterine cancer	0.000634	0.0174	CbGeAlD
Sertraline—MAOA—female reproductive system—uterine cancer	0.000609	0.0167	CbGeAlD
Sertraline—CYP2B6—renal system—uterine cancer	0.000608	0.0167	CbGeAlD
Sertraline—CYP2C19—vagina—uterine cancer	0.000562	0.0154	CbGeAlD
Sertraline—MAOA—female gonad—uterine cancer	0.000554	0.0152	CbGeAlD
Sertraline—MAOA—vagina—uterine cancer	0.000551	0.0151	CbGeAlD
Sertraline—CYP2B6—female reproductive system—uterine cancer	0.000487	0.0134	CbGeAlD
Sertraline—CYP2C9—female reproductive system—uterine cancer	0.000482	0.0132	CbGeAlD
Sertraline—CYP3A4—renal system—uterine cancer	0.000459	0.0126	CbGeAlD
Sertraline—CYP2D6—renal system—uterine cancer	0.000452	0.0124	CbGeAlD
Sertraline—ABCB1—myometrium—uterine cancer	0.000446	0.0122	CbGeAlD
Sertraline—CYP2B6—vagina—uterine cancer	0.00044	0.0121	CbGeAlD
Sertraline—SIGMAR1—lymph node—uterine cancer	0.000436	0.012	CbGeAlD
Sertraline—MAOB—lymph node—uterine cancer	0.000417	0.0114	CbGeAlD
Sertraline—SLC6A2—lymph node—uterine cancer	0.000386	0.0106	CbGeAlD
Sertraline—CYP3A4—female reproductive system—uterine cancer	0.000368	0.0101	CbGeAlD
Sertraline—CYP2D6—female reproductive system—uterine cancer	0.000362	0.00992	CbGeAlD
Sertraline—MAOA—lymph node—uterine cancer	0.000356	0.00977	CbGeAlD
Sertraline—ABCB1—epithelium—uterine cancer	0.00035	0.00961	CbGeAlD
Sertraline—ABCB1—uterine cervix—uterine cancer	0.000347	0.00953	CbGeAlD
Sertraline—ABCB1—decidua—uterine cancer	0.000331	0.00908	CbGeAlD
Sertraline—CYP2D6—female gonad—uterine cancer	0.000329	0.00903	CbGeAlD
Sertraline—ABCB1—renal system—uterine cancer	0.000325	0.00891	CbGeAlD
Sertraline—ABCB1—endometrium—uterine cancer	0.000314	0.00862	CbGeAlD
Sertraline—ABCB1—mammalian vulva—uterine cancer	0.000304	0.00833	CbGeAlD
Sertraline—ABCB1—uterus—uterine cancer	0.000289	0.00794	CbGeAlD
Sertraline—ABCB1—female reproductive system—uterine cancer	0.00026	0.00714	CbGeAlD
Sertraline—ABCB1—female gonad—uterine cancer	0.000237	0.00649	CbGeAlD
Sertraline—ABCB1—vagina—uterine cancer	0.000235	0.00646	CbGeAlD
Sertraline—ABCB1—lymph node—uterine cancer	0.000152	0.00418	CbGeAlD
Sertraline—Pancytopenia—Epirubicin—uterine cancer	0.000126	0.000446	CcSEcCtD
Sertraline—Hypotension—Etoposide—uterine cancer	0.000126	0.000445	CcSEcCtD
Sertraline—Gastritis—Doxorubicin—uterine cancer	0.000126	0.000445	CcSEcCtD
Sertraline—Alanine aminotransferase increased—Doxorubicin—uterine cancer	0.000125	0.000443	CcSEcCtD
Sertraline—Muscular weakness—Doxorubicin—uterine cancer	0.000125	0.000443	CcSEcCtD
Sertraline—Dysuria—Epirubicin—uterine cancer	0.000124	0.000439	CcSEcCtD
Sertraline—Abdominal distension—Doxorubicin—uterine cancer	0.000123	0.000437	CcSEcCtD
Sertraline—Upper respiratory tract infection—Epirubicin—uterine cancer	0.000123	0.000436	CcSEcCtD
Sertraline—Dysphagia—Doxorubicin—uterine cancer	0.000123	0.000434	CcSEcCtD
Sertraline—Pollakiuria—Epirubicin—uterine cancer	0.000122	0.000433	CcSEcCtD
Sertraline—Photosensitivity reaction—Epirubicin—uterine cancer	0.000121	0.000428	CcSEcCtD
Sertraline—Paraesthesia—Etoposide—uterine cancer	0.000121	0.000427	CcSEcCtD
Sertraline—Weight increased—Epirubicin—uterine cancer	0.000121	0.000427	CcSEcCtD
Sertraline—Pancreatitis—Doxorubicin—uterine cancer	0.00012	0.000426	CcSEcCtD
Sertraline—Weight decreased—Epirubicin—uterine cancer	0.00012	0.000424	CcSEcCtD
Sertraline—Dyspnoea—Etoposide—uterine cancer	0.00012	0.000424	CcSEcCtD
Sertraline—Hyperglycaemia—Epirubicin—uterine cancer	0.000119	0.000423	CcSEcCtD
Sertraline—Somnolence—Etoposide—uterine cancer	0.000119	0.000423	CcSEcCtD
Sertraline—Drowsiness—Epirubicin—uterine cancer	0.000118	0.000418	CcSEcCtD
Sertraline—Vomiting—Dactinomycin—uterine cancer	0.000118	0.000418	CcSEcCtD
Sertraline—Bronchitis—Doxorubicin—uterine cancer	0.000118	0.000418	CcSEcCtD
Sertraline—Stevens-Johnson syndrome—Epirubicin—uterine cancer	0.000117	0.000415	CcSEcCtD
Sertraline—Rash—Dactinomycin—uterine cancer	0.000117	0.000415	CcSEcCtD
Sertraline—Decreased appetite—Etoposide—uterine cancer	0.000117	0.000414	CcSEcCtD
Sertraline—Pancytopenia—Doxorubicin—uterine cancer	0.000116	0.000412	CcSEcCtD
Sertraline—Gastrointestinal disorder—Etoposide—uterine cancer	0.000116	0.000411	CcSEcCtD
Sertraline—Fatigue—Etoposide—uterine cancer	0.000116	0.00041	CcSEcCtD
Sertraline—Neuropathy peripheral—Epirubicin—uterine cancer	0.000116	0.00041	CcSEcCtD
Sertraline—Stomatitis—Epirubicin—uterine cancer	0.000115	0.000408	CcSEcCtD
Sertraline—Jaundice—Epirubicin—uterine cancer	0.000115	0.000408	CcSEcCtD
Sertraline—Pain—Etoposide—uterine cancer	0.000115	0.000407	CcSEcCtD
Sertraline—Constipation—Etoposide—uterine cancer	0.000115	0.000407	CcSEcCtD
Sertraline—Conjunctivitis—Epirubicin—uterine cancer	0.000115	0.000407	CcSEcCtD
Sertraline—Dysuria—Doxorubicin—uterine cancer	0.000115	0.000406	CcSEcCtD
Sertraline—Upper respiratory tract infection—Doxorubicin—uterine cancer	0.000114	0.000403	CcSEcCtD
Sertraline—Sweating—Epirubicin—uterine cancer	0.000113	0.000401	CcSEcCtD
Sertraline—Pollakiuria—Doxorubicin—uterine cancer	0.000113	0.000401	CcSEcCtD
Sertraline—Haematuria—Epirubicin—uterine cancer	0.000113	0.000399	CcSEcCtD
Sertraline—Photosensitivity reaction—Doxorubicin—uterine cancer	0.000112	0.000396	CcSEcCtD
Sertraline—Hepatobiliary disease—Epirubicin—uterine cancer	0.000112	0.000396	CcSEcCtD
Sertraline—Weight increased—Doxorubicin—uterine cancer	0.000112	0.000395	CcSEcCtD
Sertraline—Epistaxis—Epirubicin—uterine cancer	0.000111	0.000395	CcSEcCtD
Sertraline—Weight decreased—Doxorubicin—uterine cancer	0.000111	0.000393	CcSEcCtD
Sertraline—Sinusitis—Epirubicin—uterine cancer	0.000111	0.000392	CcSEcCtD
Sertraline—Feeling abnormal—Etoposide—uterine cancer	0.000111	0.000392	CcSEcCtD
Sertraline—Hyperglycaemia—Doxorubicin—uterine cancer	0.000111	0.000392	CcSEcCtD
Sertraline—Nausea—Dactinomycin—uterine cancer	0.00011	0.000391	CcSEcCtD
Sertraline—Agranulocytosis—Epirubicin—uterine cancer	0.00011	0.00039	CcSEcCtD
Sertraline—Gastrointestinal pain—Etoposide—uterine cancer	0.00011	0.000389	CcSEcCtD
Sertraline—Drowsiness—Doxorubicin—uterine cancer	0.000109	0.000387	CcSEcCtD
Sertraline—Stevens-Johnson syndrome—Doxorubicin—uterine cancer	0.000108	0.000384	CcSEcCtD
Sertraline—Bradycardia—Epirubicin—uterine cancer	0.000108	0.000382	CcSEcCtD
Sertraline—Neuropathy peripheral—Doxorubicin—uterine cancer	0.000107	0.000379	CcSEcCtD
Sertraline—Urticaria—Etoposide—uterine cancer	0.000107	0.000378	CcSEcCtD
Sertraline—Haemoglobin—Epirubicin—uterine cancer	0.000107	0.000377	CcSEcCtD
Sertraline—Stomatitis—Doxorubicin—uterine cancer	0.000107	0.000377	CcSEcCtD
Sertraline—Jaundice—Doxorubicin—uterine cancer	0.000107	0.000377	CcSEcCtD
Sertraline—Rhinitis—Epirubicin—uterine cancer	0.000106	0.000377	CcSEcCtD
Sertraline—Body temperature increased—Etoposide—uterine cancer	0.000106	0.000376	CcSEcCtD
Sertraline—Abdominal pain—Etoposide—uterine cancer	0.000106	0.000376	CcSEcCtD
Sertraline—Conjunctivitis—Doxorubicin—uterine cancer	0.000106	0.000376	CcSEcCtD
Sertraline—Haemorrhage—Epirubicin—uterine cancer	0.000106	0.000376	CcSEcCtD
Sertraline—Hepatitis—Epirubicin—uterine cancer	0.000106	0.000376	CcSEcCtD
Sertraline—Hypoaesthesia—Epirubicin—uterine cancer	0.000105	0.000374	CcSEcCtD
Sertraline—Pharyngitis—Epirubicin—uterine cancer	0.000105	0.000373	CcSEcCtD
Sertraline—Sweating—Doxorubicin—uterine cancer	0.000105	0.000371	CcSEcCtD
Sertraline—Urinary tract disorder—Epirubicin—uterine cancer	0.000105	0.000371	CcSEcCtD
Sertraline—Oedema peripheral—Epirubicin—uterine cancer	0.000104	0.00037	CcSEcCtD
Sertraline—Haematuria—Doxorubicin—uterine cancer	0.000104	0.000369	CcSEcCtD
Sertraline—Connective tissue disorder—Epirubicin—uterine cancer	0.000104	0.000369	CcSEcCtD
Sertraline—Urethral disorder—Epirubicin—uterine cancer	0.000104	0.000368	CcSEcCtD
Sertraline—Hepatobiliary disease—Doxorubicin—uterine cancer	0.000103	0.000366	CcSEcCtD
Sertraline—Epistaxis—Doxorubicin—uterine cancer	0.000103	0.000365	CcSEcCtD
Sertraline—Sinusitis—Doxorubicin—uterine cancer	0.000103	0.000363	CcSEcCtD
Sertraline—Visual impairment—Epirubicin—uterine cancer	0.000102	0.000362	CcSEcCtD
Sertraline—Agranulocytosis—Doxorubicin—uterine cancer	0.000102	0.000361	CcSEcCtD
Sertraline—Erythema multiforme—Epirubicin—uterine cancer	0.0001	0.000355	CcSEcCtD
Sertraline—Bradycardia—Doxorubicin—uterine cancer	9.99e-05	0.000354	CcSEcCtD
Sertraline—Eye disorder—Epirubicin—uterine cancer	9.91e-05	0.000351	CcSEcCtD
Sertraline—Hypersensitivity—Etoposide—uterine cancer	9.9e-05	0.000351	CcSEcCtD
Sertraline—Tinnitus—Epirubicin—uterine cancer	9.89e-05	0.00035	CcSEcCtD
Sertraline—Haemoglobin—Doxorubicin—uterine cancer	9.86e-05	0.000349	CcSEcCtD
Sertraline—Cardiac disorder—Epirubicin—uterine cancer	9.84e-05	0.000349	CcSEcCtD
Sertraline—Flushing—Epirubicin—uterine cancer	9.84e-05	0.000349	CcSEcCtD
Sertraline—Rhinitis—Doxorubicin—uterine cancer	9.84e-05	0.000348	CcSEcCtD
Sertraline—Hepatitis—Doxorubicin—uterine cancer	9.81e-05	0.000347	CcSEcCtD
Sertraline—Haemorrhage—Doxorubicin—uterine cancer	9.81e-05	0.000347	CcSEcCtD
Sertraline—Hypoaesthesia—Doxorubicin—uterine cancer	9.76e-05	0.000346	CcSEcCtD
Sertraline—Pharyngitis—Doxorubicin—uterine cancer	9.74e-05	0.000345	CcSEcCtD
Sertraline—Urinary tract disorder—Doxorubicin—uterine cancer	9.69e-05	0.000343	CcSEcCtD
Sertraline—Oedema peripheral—Doxorubicin—uterine cancer	9.66e-05	0.000342	CcSEcCtD
Sertraline—Asthenia—Etoposide—uterine cancer	9.64e-05	0.000342	CcSEcCtD
Sertraline—Connective tissue disorder—Doxorubicin—uterine cancer	9.64e-05	0.000341	CcSEcCtD
Sertraline—Angiopathy—Epirubicin—uterine cancer	9.62e-05	0.000341	CcSEcCtD
Sertraline—Urethral disorder—Doxorubicin—uterine cancer	9.62e-05	0.000341	CcSEcCtD
Sertraline—Immune system disorder—Epirubicin—uterine cancer	9.58e-05	0.000339	CcSEcCtD
Sertraline—Mediastinal disorder—Epirubicin—uterine cancer	9.56e-05	0.000338	CcSEcCtD
Sertraline—Chills—Epirubicin—uterine cancer	9.51e-05	0.000337	CcSEcCtD
Sertraline—Pruritus—Etoposide—uterine cancer	9.51e-05	0.000337	CcSEcCtD
Sertraline—Arrhythmia—Epirubicin—uterine cancer	9.47e-05	0.000335	CcSEcCtD
Sertraline—Visual impairment—Doxorubicin—uterine cancer	9.45e-05	0.000335	CcSEcCtD
Sertraline—Alopecia—Epirubicin—uterine cancer	9.37e-05	0.000332	CcSEcCtD
Sertraline—Mental disorder—Epirubicin—uterine cancer	9.29e-05	0.000329	CcSEcCtD
Sertraline—Erythema multiforme—Doxorubicin—uterine cancer	9.28e-05	0.000329	CcSEcCtD
Sertraline—Erythema—Epirubicin—uterine cancer	9.23e-05	0.000327	CcSEcCtD
Sertraline—Malnutrition—Epirubicin—uterine cancer	9.23e-05	0.000327	CcSEcCtD
Sertraline—Diarrhoea—Etoposide—uterine cancer	9.19e-05	0.000326	CcSEcCtD
Sertraline—Eye disorder—Doxorubicin—uterine cancer	9.17e-05	0.000325	CcSEcCtD
Sertraline—Tinnitus—Doxorubicin—uterine cancer	9.15e-05	0.000324	CcSEcCtD
Sertraline—Flushing—Doxorubicin—uterine cancer	9.1e-05	0.000322	CcSEcCtD
Sertraline—Cardiac disorder—Doxorubicin—uterine cancer	9.1e-05	0.000322	CcSEcCtD
Sertraline—Flatulence—Epirubicin—uterine cancer	9.09e-05	0.000322	CcSEcCtD
Sertraline—Tension—Epirubicin—uterine cancer	9.06e-05	0.000321	CcSEcCtD
Sertraline—Dysgeusia—Epirubicin—uterine cancer	9.04e-05	0.00032	CcSEcCtD
Sertraline—Nervousness—Epirubicin—uterine cancer	8.96e-05	0.000318	CcSEcCtD
Sertraline—Back pain—Epirubicin—uterine cancer	8.93e-05	0.000316	CcSEcCtD
Sertraline—Angiopathy—Doxorubicin—uterine cancer	8.9e-05	0.000315	CcSEcCtD
Sertraline—Dizziness—Etoposide—uterine cancer	8.89e-05	0.000315	CcSEcCtD
Sertraline—Muscle spasms—Epirubicin—uterine cancer	8.87e-05	0.000314	CcSEcCtD
Sertraline—Immune system disorder—Doxorubicin—uterine cancer	8.86e-05	0.000314	CcSEcCtD
Sertraline—Mediastinal disorder—Doxorubicin—uterine cancer	8.84e-05	0.000313	CcSEcCtD
Sertraline—Chills—Doxorubicin—uterine cancer	8.8e-05	0.000312	CcSEcCtD
Sertraline—Arrhythmia—Doxorubicin—uterine cancer	8.76e-05	0.00031	CcSEcCtD
Sertraline—Alopecia—Doxorubicin—uterine cancer	8.67e-05	0.000307	CcSEcCtD
Sertraline—Mental disorder—Doxorubicin—uterine cancer	8.59e-05	0.000304	CcSEcCtD
Sertraline—Ill-defined disorder—Epirubicin—uterine cancer	8.56e-05	0.000303	CcSEcCtD
Sertraline—Vomiting—Etoposide—uterine cancer	8.54e-05	0.000303	CcSEcCtD
Sertraline—Malnutrition—Doxorubicin—uterine cancer	8.54e-05	0.000302	CcSEcCtD
Sertraline—Erythema—Doxorubicin—uterine cancer	8.54e-05	0.000302	CcSEcCtD
Sertraline—Anaemia—Epirubicin—uterine cancer	8.53e-05	0.000302	CcSEcCtD
Sertraline—Agitation—Epirubicin—uterine cancer	8.48e-05	0.0003	CcSEcCtD
Sertraline—Rash—Etoposide—uterine cancer	8.47e-05	0.0003	CcSEcCtD
Sertraline—Dermatitis—Etoposide—uterine cancer	8.47e-05	0.0003	CcSEcCtD
Sertraline—Headache—Etoposide—uterine cancer	8.42e-05	0.000298	CcSEcCtD
Sertraline—Flatulence—Doxorubicin—uterine cancer	8.42e-05	0.000298	CcSEcCtD
Sertraline—Tension—Doxorubicin—uterine cancer	8.38e-05	0.000297	CcSEcCtD
Sertraline—Dysgeusia—Doxorubicin—uterine cancer	8.36e-05	0.000296	CcSEcCtD
Sertraline—Malaise—Epirubicin—uterine cancer	8.32e-05	0.000295	CcSEcCtD
Sertraline—Nervousness—Doxorubicin—uterine cancer	8.29e-05	0.000294	CcSEcCtD
Sertraline—Vertigo—Epirubicin—uterine cancer	8.29e-05	0.000294	CcSEcCtD
Sertraline—Syncope—Epirubicin—uterine cancer	8.28e-05	0.000293	CcSEcCtD
Sertraline—Leukopenia—Epirubicin—uterine cancer	8.26e-05	0.000293	CcSEcCtD
Sertraline—Back pain—Doxorubicin—uterine cancer	8.26e-05	0.000293	CcSEcCtD
Sertraline—Muscle spasms—Doxorubicin—uterine cancer	8.21e-05	0.000291	CcSEcCtD
Sertraline—Palpitations—Epirubicin—uterine cancer	8.16e-05	0.000289	CcSEcCtD
Sertraline—Loss of consciousness—Epirubicin—uterine cancer	8.11e-05	0.000287	CcSEcCtD
Sertraline—Cough—Epirubicin—uterine cancer	8.05e-05	0.000285	CcSEcCtD
Sertraline—Convulsion—Epirubicin—uterine cancer	8e-05	0.000283	CcSEcCtD
Sertraline—Nausea—Etoposide—uterine cancer	7.98e-05	0.000283	CcSEcCtD
Sertraline—Hypertension—Epirubicin—uterine cancer	7.97e-05	0.000282	CcSEcCtD
Sertraline—Ill-defined disorder—Doxorubicin—uterine cancer	7.92e-05	0.000281	CcSEcCtD
Sertraline—Anaemia—Doxorubicin—uterine cancer	7.89e-05	0.00028	CcSEcCtD
Sertraline—Chest pain—Epirubicin—uterine cancer	7.86e-05	0.000278	CcSEcCtD
Sertraline—Arthralgia—Epirubicin—uterine cancer	7.86e-05	0.000278	CcSEcCtD
Sertraline—Myalgia—Epirubicin—uterine cancer	7.86e-05	0.000278	CcSEcCtD
Sertraline—Agitation—Doxorubicin—uterine cancer	7.85e-05	0.000278	CcSEcCtD
Sertraline—Anxiety—Epirubicin—uterine cancer	7.83e-05	0.000277	CcSEcCtD
Sertraline—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—uterine cancer	7.8e-05	0.000276	CcSEcCtD
Sertraline—Discomfort—Epirubicin—uterine cancer	7.76e-05	0.000275	CcSEcCtD
Sertraline—Malaise—Doxorubicin—uterine cancer	7.7e-05	0.000273	CcSEcCtD
Sertraline—Dry mouth—Epirubicin—uterine cancer	7.69e-05	0.000272	CcSEcCtD
Sertraline—Vertigo—Doxorubicin—uterine cancer	7.67e-05	0.000272	CcSEcCtD
Sertraline—Syncope—Doxorubicin—uterine cancer	7.66e-05	0.000271	CcSEcCtD
Sertraline—Leukopenia—Doxorubicin—uterine cancer	7.64e-05	0.000271	CcSEcCtD
Sertraline—Confusional state—Epirubicin—uterine cancer	7.6e-05	0.000269	CcSEcCtD
Sertraline—Palpitations—Doxorubicin—uterine cancer	7.55e-05	0.000267	CcSEcCtD
Sertraline—Oedema—Epirubicin—uterine cancer	7.53e-05	0.000267	CcSEcCtD
Sertraline—Anaphylactic shock—Epirubicin—uterine cancer	7.53e-05	0.000267	CcSEcCtD
Sertraline—Loss of consciousness—Doxorubicin—uterine cancer	7.51e-05	0.000266	CcSEcCtD
Sertraline—Cough—Doxorubicin—uterine cancer	7.45e-05	0.000264	CcSEcCtD
Sertraline—Shock—Epirubicin—uterine cancer	7.41e-05	0.000263	CcSEcCtD
Sertraline—Convulsion—Doxorubicin—uterine cancer	7.4e-05	0.000262	CcSEcCtD
Sertraline—Nervous system disorder—Epirubicin—uterine cancer	7.39e-05	0.000262	CcSEcCtD
Sertraline—Thrombocytopenia—Epirubicin—uterine cancer	7.38e-05	0.000261	CcSEcCtD
Sertraline—Hypertension—Doxorubicin—uterine cancer	7.37e-05	0.000261	CcSEcCtD
Sertraline—Tachycardia—Epirubicin—uterine cancer	7.35e-05	0.00026	CcSEcCtD
Sertraline—Skin disorder—Epirubicin—uterine cancer	7.32e-05	0.000259	CcSEcCtD
Sertraline—Hyperhidrosis—Epirubicin—uterine cancer	7.28e-05	0.000258	CcSEcCtD
Sertraline—Chest pain—Doxorubicin—uterine cancer	7.27e-05	0.000258	CcSEcCtD
Sertraline—Myalgia—Doxorubicin—uterine cancer	7.27e-05	0.000258	CcSEcCtD
Sertraline—Arthralgia—Doxorubicin—uterine cancer	7.27e-05	0.000258	CcSEcCtD
Sertraline—Anxiety—Doxorubicin—uterine cancer	7.25e-05	0.000257	CcSEcCtD
Sertraline—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—uterine cancer	7.22e-05	0.000256	CcSEcCtD
Sertraline—Discomfort—Doxorubicin—uterine cancer	7.18e-05	0.000254	CcSEcCtD
Sertraline—Anorexia—Epirubicin—uterine cancer	7.18e-05	0.000254	CcSEcCtD
Sertraline—Dry mouth—Doxorubicin—uterine cancer	7.11e-05	0.000252	CcSEcCtD
Sertraline—Hypotension—Epirubicin—uterine cancer	7.04e-05	0.000249	CcSEcCtD
Sertraline—Confusional state—Doxorubicin—uterine cancer	7.03e-05	0.000249	CcSEcCtD
Sertraline—Anaphylactic shock—Doxorubicin—uterine cancer	6.97e-05	0.000247	CcSEcCtD
Sertraline—Oedema—Doxorubicin—uterine cancer	6.97e-05	0.000247	CcSEcCtD
Sertraline—Musculoskeletal discomfort—Epirubicin—uterine cancer	6.86e-05	0.000243	CcSEcCtD
Sertraline—Shock—Doxorubicin—uterine cancer	6.86e-05	0.000243	CcSEcCtD
Sertraline—Nervous system disorder—Doxorubicin—uterine cancer	6.84e-05	0.000242	CcSEcCtD
Sertraline—Thrombocytopenia—Doxorubicin—uterine cancer	6.82e-05	0.000242	CcSEcCtD
Sertraline—Insomnia—Epirubicin—uterine cancer	6.81e-05	0.000241	CcSEcCtD
Sertraline—Tachycardia—Doxorubicin—uterine cancer	6.8e-05	0.000241	CcSEcCtD
Sertraline—Skin disorder—Doxorubicin—uterine cancer	6.77e-05	0.00024	CcSEcCtD
Sertraline—Paraesthesia—Epirubicin—uterine cancer	6.76e-05	0.00024	CcSEcCtD
Sertraline—Hyperhidrosis—Doxorubicin—uterine cancer	6.74e-05	0.000239	CcSEcCtD
Sertraline—Dyspnoea—Epirubicin—uterine cancer	6.72e-05	0.000238	CcSEcCtD
Sertraline—Somnolence—Epirubicin—uterine cancer	6.7e-05	0.000237	CcSEcCtD
Sertraline—Anorexia—Doxorubicin—uterine cancer	6.64e-05	0.000235	CcSEcCtD
Sertraline—Dyspepsia—Epirubicin—uterine cancer	6.63e-05	0.000235	CcSEcCtD
Sertraline—Decreased appetite—Epirubicin—uterine cancer	6.55e-05	0.000232	CcSEcCtD
Sertraline—Hypotension—Doxorubicin—uterine cancer	6.51e-05	0.000231	CcSEcCtD
Sertraline—Gastrointestinal disorder—Epirubicin—uterine cancer	6.5e-05	0.00023	CcSEcCtD
Sertraline—Fatigue—Epirubicin—uterine cancer	6.49e-05	0.00023	CcSEcCtD
Sertraline—Pain—Epirubicin—uterine cancer	6.44e-05	0.000228	CcSEcCtD
Sertraline—Constipation—Epirubicin—uterine cancer	6.44e-05	0.000228	CcSEcCtD
Sertraline—Musculoskeletal discomfort—Doxorubicin—uterine cancer	6.35e-05	0.000225	CcSEcCtD
Sertraline—Insomnia—Doxorubicin—uterine cancer	6.3e-05	0.000223	CcSEcCtD
Sertraline—Paraesthesia—Doxorubicin—uterine cancer	6.26e-05	0.000222	CcSEcCtD
Sertraline—Dyspnoea—Doxorubicin—uterine cancer	6.21e-05	0.00022	CcSEcCtD
Sertraline—Feeling abnormal—Epirubicin—uterine cancer	6.21e-05	0.00022	CcSEcCtD
Sertraline—Somnolence—Doxorubicin—uterine cancer	6.2e-05	0.000219	CcSEcCtD
Sertraline—Gastrointestinal pain—Epirubicin—uterine cancer	6.16e-05	0.000218	CcSEcCtD
Sertraline—Dyspepsia—Doxorubicin—uterine cancer	6.14e-05	0.000217	CcSEcCtD
Sertraline—Decreased appetite—Doxorubicin—uterine cancer	6.06e-05	0.000215	CcSEcCtD
Sertraline—Gastrointestinal disorder—Doxorubicin—uterine cancer	6.02e-05	0.000213	CcSEcCtD
Sertraline—Fatigue—Doxorubicin—uterine cancer	6.01e-05	0.000213	CcSEcCtD
Sertraline—Urticaria—Epirubicin—uterine cancer	5.98e-05	0.000212	CcSEcCtD
Sertraline—Constipation—Doxorubicin—uterine cancer	5.96e-05	0.000211	CcSEcCtD
Sertraline—Pain—Doxorubicin—uterine cancer	5.96e-05	0.000211	CcSEcCtD
Sertraline—Body temperature increased—Epirubicin—uterine cancer	5.95e-05	0.000211	CcSEcCtD
Sertraline—Abdominal pain—Epirubicin—uterine cancer	5.95e-05	0.000211	CcSEcCtD
Sertraline—Feeling abnormal—Doxorubicin—uterine cancer	5.74e-05	0.000203	CcSEcCtD
Sertraline—Gastrointestinal pain—Doxorubicin—uterine cancer	5.7e-05	0.000202	CcSEcCtD
Sertraline—Hypersensitivity—Epirubicin—uterine cancer	5.55e-05	0.000197	CcSEcCtD
Sertraline—Urticaria—Doxorubicin—uterine cancer	5.54e-05	0.000196	CcSEcCtD
Sertraline—Abdominal pain—Doxorubicin—uterine cancer	5.51e-05	0.000195	CcSEcCtD
Sertraline—Body temperature increased—Doxorubicin—uterine cancer	5.51e-05	0.000195	CcSEcCtD
Sertraline—Asthenia—Epirubicin—uterine cancer	5.4e-05	0.000191	CcSEcCtD
Sertraline—Pruritus—Epirubicin—uterine cancer	5.33e-05	0.000189	CcSEcCtD
Sertraline—Diarrhoea—Epirubicin—uterine cancer	5.15e-05	0.000183	CcSEcCtD
Sertraline—Hypersensitivity—Doxorubicin—uterine cancer	5.14e-05	0.000182	CcSEcCtD
Sertraline—Asthenia—Doxorubicin—uterine cancer	5e-05	0.000177	CcSEcCtD
Sertraline—Dizziness—Epirubicin—uterine cancer	4.98e-05	0.000176	CcSEcCtD
Sertraline—Pruritus—Doxorubicin—uterine cancer	4.93e-05	0.000175	CcSEcCtD
Sertraline—Vomiting—Epirubicin—uterine cancer	4.79e-05	0.00017	CcSEcCtD
Sertraline—Diarrhoea—Doxorubicin—uterine cancer	4.77e-05	0.000169	CcSEcCtD
Sertraline—Rash—Epirubicin—uterine cancer	4.75e-05	0.000168	CcSEcCtD
Sertraline—Dermatitis—Epirubicin—uterine cancer	4.75e-05	0.000168	CcSEcCtD
Sertraline—Headache—Epirubicin—uterine cancer	4.72e-05	0.000167	CcSEcCtD
Sertraline—Dizziness—Doxorubicin—uterine cancer	4.61e-05	0.000163	CcSEcCtD
Sertraline—Nausea—Epirubicin—uterine cancer	4.47e-05	0.000158	CcSEcCtD
Sertraline—Vomiting—Doxorubicin—uterine cancer	4.43e-05	0.000157	CcSEcCtD
Sertraline—Rash—Doxorubicin—uterine cancer	4.39e-05	0.000156	CcSEcCtD
Sertraline—Dermatitis—Doxorubicin—uterine cancer	4.39e-05	0.000156	CcSEcCtD
Sertraline—Headache—Doxorubicin—uterine cancer	4.37e-05	0.000155	CcSEcCtD
Sertraline—Nausea—Doxorubicin—uterine cancer	4.14e-05	0.000147	CcSEcCtD
Sertraline—CYP2C19—Metapathway biotransformation—AKR1C3—uterine cancer	1.27e-05	0.00269	CbGpPWpGaD
Sertraline—CYP2D6—Biological oxidations—CYP11A1—uterine cancer	1.26e-05	0.00266	CbGpPWpGaD
Sertraline—CYP2C9—Biological oxidations—CYP11A1—uterine cancer	1.25e-05	0.00264	CbGpPWpGaD
Sertraline—CYP2D6—Metapathway biotransformation—CYP11A1—uterine cancer	1.24e-05	0.00262	CbGpPWpGaD
Sertraline—CYP2C9—Metapathway biotransformation—CYP11A1—uterine cancer	1.23e-05	0.0026	CbGpPWpGaD
Sertraline—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—CDKN1B—uterine cancer	1.22e-05	0.00258	CbGpPWpGaD
Sertraline—CYP2C19—Metabolism of lipids and lipoproteins—SRD5A2—uterine cancer	1.21e-05	0.00257	CbGpPWpGaD
Sertraline—SLC6A4—SIDS Susceptibility Pathways—CTNNB1—uterine cancer	1.2e-05	0.00254	CbGpPWpGaD
Sertraline—CYP2D6—Metapathway biotransformation—AKR1C3—uterine cancer	1.17e-05	0.00248	CbGpPWpGaD
Sertraline—CYP2C9—Metapathway biotransformation—AKR1C3—uterine cancer	1.16e-05	0.00246	CbGpPWpGaD
Sertraline—MAOA—Metabolism—NDUFB11—uterine cancer	1.14e-05	0.00242	CbGpPWpGaD
Sertraline—MAOA—Metabolism—SRD5A2—uterine cancer	1.14e-05	0.00242	CbGpPWpGaD
Sertraline—CYP3A4—Phase 1 - Functionalization of compounds—CYP19A1—uterine cancer	1.14e-05	0.00241	CbGpPWpGaD
Sertraline—CYP1A2—Metapathway biotransformation—GPX3—uterine cancer	1.13e-05	0.00239	CbGpPWpGaD
Sertraline—SLC6A4—SIDS Susceptibility Pathways—EP300—uterine cancer	1.12e-05	0.00236	CbGpPWpGaD
Sertraline—CYP2C9—Metabolism of lipids and lipoproteins—SRD5A2—uterine cancer	1.11e-05	0.00234	CbGpPWpGaD
Sertraline—ABCB1—Integrated Pancreatic Cancer Pathway—EZH2—uterine cancer	1.07e-05	0.00227	CbGpPWpGaD
Sertraline—MAOA—SIDS Susceptibility Pathways—CXCL8—uterine cancer	1.07e-05	0.00226	CbGpPWpGaD
Sertraline—CYP1A2—Biological oxidations—CYP11A1—uterine cancer	1.06e-05	0.00225	CbGpPWpGaD
Sertraline—SLC6A4—SIDS Susceptibility Pathways—VEGFA—uterine cancer	1.06e-05	0.00224	CbGpPWpGaD
Sertraline—CYP1A2—Metapathway biotransformation—CYP11A1—uterine cancer	1.05e-05	0.00222	CbGpPWpGaD
Sertraline—MAOB—Metabolism—POLD1—uterine cancer	1.03e-05	0.00218	CbGpPWpGaD
Sertraline—CYP1A2—Aryl Hydrocarbon Receptor—CDKN1B—uterine cancer	1.02e-05	0.00216	CbGpPWpGaD
Sertraline—CYP1A2—Aryl Hydrocarbon Receptor Pathway—CDKN1B—uterine cancer	1.02e-05	0.00216	CbGpPWpGaD
Sertraline—CYP2C19—Biological oxidations—CYP19A1—uterine cancer	1e-05	0.00213	CbGpPWpGaD
Sertraline—CYP3A4—Metapathway biotransformation—AKR1C1—uterine cancer	9.93e-06	0.0021	CbGpPWpGaD
Sertraline—ABCB1—Integrated Pancreatic Cancer Pathway—ESR2—uterine cancer	9.93e-06	0.0021	CbGpPWpGaD
Sertraline—CYP1A2—Metapathway biotransformation—AKR1C3—uterine cancer	9.91e-06	0.0021	CbGpPWpGaD
Sertraline—CYP2C19—Metapathway biotransformation—CYP19A1—uterine cancer	9.91e-06	0.0021	CbGpPWpGaD
Sertraline—MAOA—SIDS Susceptibility Pathways—CTNNB1—uterine cancer	9.84e-06	0.00208	CbGpPWpGaD
Sertraline—MAOB—Metabolism—AKR1C1—uterine cancer	9.65e-06	0.00204	CbGpPWpGaD
Sertraline—SLC6A4—Circadian rythm related genes—PTEN—uterine cancer	9.56e-06	0.00202	CbGpPWpGaD
Sertraline—CYP1A2—Metabolism of lipids and lipoproteins—SRD5A2—uterine cancer	9.45e-06	0.002	CbGpPWpGaD
Sertraline—CYP2D6—Biological oxidations—CYP19A1—uterine cancer	9.24e-06	0.00196	CbGpPWpGaD
Sertraline—CYP2C9—Biological oxidations—CYP19A1—uterine cancer	9.16e-06	0.00194	CbGpPWpGaD
Sertraline—MAOA—SIDS Susceptibility Pathways—EP300—uterine cancer	9.15e-06	0.00194	CbGpPWpGaD
Sertraline—SLC6A4—Circadian rythm related genes—EP300—uterine cancer	9.11e-06	0.00193	CbGpPWpGaD
Sertraline—CYP2D6—Metapathway biotransformation—CYP19A1—uterine cancer	9.11e-06	0.00193	CbGpPWpGaD
Sertraline—CYP2C9—Metapathway biotransformation—CYP19A1—uterine cancer	9.03e-06	0.00191	CbGpPWpGaD
Sertraline—ABCB1—Integrated Pancreatic Cancer Pathway—STK11—uterine cancer	9.02e-06	0.00191	CbGpPWpGaD
Sertraline—CYP1A2—Aryl Hydrocarbon Receptor—EP300—uterine cancer	8.96e-06	0.0019	CbGpPWpGaD
Sertraline—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EP300—uterine cancer	8.96e-06	0.0019	CbGpPWpGaD
Sertraline—CYP2C19—Metabolism of lipids and lipoproteins—AKR1B1—uterine cancer	8.76e-06	0.00186	CbGpPWpGaD
Sertraline—CYP2C19—Metabolism of lipids and lipoproteins—STAR—uterine cancer	8.76e-06	0.00186	CbGpPWpGaD
Sertraline—CYP3A4—Metapathway biotransformation—GPX3—uterine cancer	8.72e-06	0.00185	CbGpPWpGaD
Sertraline—MAOA—SIDS Susceptibility Pathways—VEGFA—uterine cancer	8.67e-06	0.00184	CbGpPWpGaD
Sertraline—MAOB—Metabolism—RRM2—uterine cancer	8.6e-06	0.00182	CbGpPWpGaD
Sertraline—ABCB1—Allograft Rejection—CXCL8—uterine cancer	8.5e-06	0.0018	CbGpPWpGaD
Sertraline—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—uterine cancer	8.49e-06	0.0018	CbGpPWpGaD
Sertraline—ABCB1—HIF-1-alpha transcription factor network—EP300—uterine cancer	8.41e-06	0.00178	CbGpPWpGaD
Sertraline—CYP1A2—Aryl Hydrocarbon Receptor—NRAS—uterine cancer	8.39e-06	0.00178	CbGpPWpGaD
Sertraline—MAOB—Metabolism—DCN—uterine cancer	8.35e-06	0.00177	CbGpPWpGaD
Sertraline—MAOA—Metabolism—STAR—uterine cancer	8.25e-06	0.00175	CbGpPWpGaD
Sertraline—MAOA—Metabolism—AKR1B1—uterine cancer	8.25e-06	0.00175	CbGpPWpGaD
Sertraline—CYP3A4—Biological oxidations—CYP11A1—uterine cancer	8.21e-06	0.00174	CbGpPWpGaD
Sertraline—ABCB1—Transmembrane transport of small molecules—ABCC9—uterine cancer	8.13e-06	0.00172	CbGpPWpGaD
Sertraline—CYP3A4—Metapathway biotransformation—CYP11A1—uterine cancer	8.1e-06	0.00172	CbGpPWpGaD
Sertraline—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN2B—uterine cancer	8.08e-06	0.00171	CbGpPWpGaD
Sertraline—CYP2C9—Metabolism of lipids and lipoproteins—AKR1B1—uterine cancer	7.99e-06	0.00169	CbGpPWpGaD
Sertraline—CYP2C9—Metabolism of lipids and lipoproteins—STAR—uterine cancer	7.99e-06	0.00169	CbGpPWpGaD
Sertraline—ABCB1—HIF-1-alpha transcription factor network—VEGFA—uterine cancer	7.97e-06	0.00169	CbGpPWpGaD
Sertraline—MAOB—Metabolism—CYP11A1—uterine cancer	7.86e-06	0.00167	CbGpPWpGaD
Sertraline—CYP1A2—Biological oxidations—CYP19A1—uterine cancer	7.83e-06	0.00166	CbGpPWpGaD
Sertraline—CYP1A2—Metapathway biotransformation—CYP19A1—uterine cancer	7.72e-06	0.00164	CbGpPWpGaD
Sertraline—CYP3A4—Metapathway biotransformation—AKR1C3—uterine cancer	7.65e-06	0.00162	CbGpPWpGaD
Sertraline—MAOB—Metabolism—AKR1C3—uterine cancer	7.43e-06	0.00157	CbGpPWpGaD
Sertraline—CYP1A2—Aryl Hydrocarbon Receptor—KRAS—uterine cancer	7.22e-06	0.00153	CbGpPWpGaD
Sertraline—CYP2B6—Metabolism—NDUFB11—uterine cancer	7.14e-06	0.00151	CbGpPWpGaD
Sertraline—CYP2B6—Metabolism—SRD5A2—uterine cancer	7.14e-06	0.00151	CbGpPWpGaD
Sertraline—ABCB1—Allograft Rejection—VEGFA—uterine cancer	6.9e-06	0.00146	CbGpPWpGaD
Sertraline—CYP1A2—Metabolism of lipids and lipoproteins—AKR1B1—uterine cancer	6.83e-06	0.00145	CbGpPWpGaD
Sertraline—CYP1A2—Metabolism of lipids and lipoproteins—STAR—uterine cancer	6.83e-06	0.00145	CbGpPWpGaD
Sertraline—SLC6A4—Circadian rythm related genes—TP53—uterine cancer	6.52e-06	0.00138	CbGpPWpGaD
Sertraline—MAOA—Metabolism—POLD1—uterine cancer	6.47e-06	0.00137	CbGpPWpGaD
Sertraline—CYP2C19—Metabolism of lipids and lipoproteins—AKR1C1—uterine cancer	6.43e-06	0.00136	CbGpPWpGaD
Sertraline—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—uterine cancer	6.13e-06	0.0013	CbGpPWpGaD
Sertraline—MAOA—Metabolism—AKR1C1—uterine cancer	6.05e-06	0.00128	CbGpPWpGaD
Sertraline—CYP3A4—Biological oxidations—CYP19A1—uterine cancer	6.04e-06	0.00128	CbGpPWpGaD
Sertraline—ABCB1—Integrated Pancreatic Cancer Pathway—ESR1—uterine cancer	6.02e-06	0.00128	CbGpPWpGaD
Sertraline—CYP3A4—Metapathway biotransformation—CYP19A1—uterine cancer	5.96e-06	0.00126	CbGpPWpGaD
Sertraline—CYP2C9—Metabolism of lipids and lipoproteins—AKR1C1—uterine cancer	5.87e-06	0.00124	CbGpPWpGaD
Sertraline—MAOB—Metabolism—CYP19A1—uterine cancer	5.78e-06	0.00123	CbGpPWpGaD
Sertraline—MAOB—Metabolism—STK11—uterine cancer	5.78e-06	0.00123	CbGpPWpGaD
Sertraline—CYP2C19—Metabolism—NDUFB11—uterine cancer	5.4e-06	0.00114	CbGpPWpGaD
Sertraline—CYP2C19—Metabolism—SRD5A2—uterine cancer	5.4e-06	0.00114	CbGpPWpGaD
Sertraline—MAOA—Metabolism—RRM2—uterine cancer	5.39e-06	0.00114	CbGpPWpGaD
Sertraline—ABCB1—Metabolism—SRD5A2—uterine cancer	5.27e-06	0.00112	CbGpPWpGaD
Sertraline—ABCB1—Metabolism—NDUFB11—uterine cancer	5.27e-06	0.00112	CbGpPWpGaD
Sertraline—CYP2C19—Metabolism of lipids and lipoproteins—CYP11A1—uterine cancer	5.24e-06	0.00111	CbGpPWpGaD
Sertraline—MAOA—Metabolism—DCN—uterine cancer	5.24e-06	0.00111	CbGpPWpGaD
Sertraline—CYP2B6—Metabolism—AKR1B1—uterine cancer	5.16e-06	0.00109	CbGpPWpGaD
Sertraline—CYP2B6—Metabolism—STAR—uterine cancer	5.16e-06	0.00109	CbGpPWpGaD
Sertraline—MAOA—Transmission across Chemical Synapses—HRAS—uterine cancer	5.13e-06	0.00109	CbGpPWpGaD
Sertraline—ABCB1—HIF-1-alpha transcription factor network—AKT1—uterine cancer	5.08e-06	0.00108	CbGpPWpGaD
Sertraline—CYP1A2—Metabolism of lipids and lipoproteins—AKR1C1—uterine cancer	5.01e-06	0.00106	CbGpPWpGaD
Sertraline—CYP2D6—Metabolism—SRD5A2—uterine cancer	4.97e-06	0.00105	CbGpPWpGaD
Sertraline—CYP2D6—Metabolism—NDUFB11—uterine cancer	4.97e-06	0.00105	CbGpPWpGaD
Sertraline—CYP2C19—Metabolism of lipids and lipoproteins—AKR1C3—uterine cancer	4.95e-06	0.00105	CbGpPWpGaD
Sertraline—MAOA—Metabolism—CYP11A1—uterine cancer	4.93e-06	0.00105	CbGpPWpGaD
Sertraline—CYP2C9—Metabolism—SRD5A2—uterine cancer	4.92e-06	0.00104	CbGpPWpGaD
Sertraline—CYP2C9—Metabolism—NDUFB11—uterine cancer	4.92e-06	0.00104	CbGpPWpGaD
Sertraline—CYP2C9—Metabolism of lipids and lipoproteins—CYP11A1—uterine cancer	4.78e-06	0.00101	CbGpPWpGaD
Sertraline—SLC6A3—Transmission across Chemical Synapses—HRAS—uterine cancer	4.77e-06	0.00101	CbGpPWpGaD
Sertraline—MAOA—Metabolism—AKR1C3—uterine cancer	4.66e-06	0.000987	CbGpPWpGaD
Sertraline—CYP2C9—Metabolism of lipids and lipoproteins—AKR1C3—uterine cancer	4.52e-06	0.000956	CbGpPWpGaD
Sertraline—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—uterine cancer	4.42e-06	0.000936	CbGpPWpGaD
Sertraline—MAOB—Metabolism—MTHFR—uterine cancer	4.35e-06	0.000921	CbGpPWpGaD
Sertraline—CYP1A2—Metabolism—NDUFB11—uterine cancer	4.21e-06	0.000891	CbGpPWpGaD
Sertraline—CYP1A2—Metabolism—SRD5A2—uterine cancer	4.21e-06	0.000891	CbGpPWpGaD
Sertraline—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1B—uterine cancer	4.09e-06	0.000867	CbGpPWpGaD
Sertraline—CYP1A2—Metabolism of lipids and lipoproteins—CYP11A1—uterine cancer	4.09e-06	0.000865	CbGpPWpGaD
Sertraline—CYP2B6—Metabolism—POLD1—uterine cancer	4.05e-06	0.000858	CbGpPWpGaD
Sertraline—MAOA—Neuronal System—HRAS—uterine cancer	3.93e-06	0.000833	CbGpPWpGaD
Sertraline—CYP2C19—Metabolism—AKR1B1—uterine cancer	3.9e-06	0.000827	CbGpPWpGaD
Sertraline—CYP2C19—Metabolism—STAR—uterine cancer	3.9e-06	0.000827	CbGpPWpGaD
Sertraline—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—uterine cancer	3.87e-06	0.000819	CbGpPWpGaD
Sertraline—CYP1A2—Metabolism of lipids and lipoproteins—AKR1C3—uterine cancer	3.86e-06	0.000817	CbGpPWpGaD
Sertraline—CYP2C19—Metabolism of lipids and lipoproteins—CYP19A1—uterine cancer	3.86e-06	0.000817	CbGpPWpGaD
Sertraline—ABCB1—Metabolism—AKR1B1—uterine cancer	3.81e-06	0.000807	CbGpPWpGaD
Sertraline—ABCB1—Metabolism—STAR—uterine cancer	3.81e-06	0.000807	CbGpPWpGaD
Sertraline—CYP2B6—Metabolism—AKR1C1—uterine cancer	3.79e-06	0.000803	CbGpPWpGaD
Sertraline—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—uterine cancer	3.77e-06	0.000798	CbGpPWpGaD
Sertraline—SLC6A3—Neuronal System—HRAS—uterine cancer	3.66e-06	0.000774	CbGpPWpGaD
Sertraline—MAOA—Metabolism—STK11—uterine cancer	3.63e-06	0.000769	CbGpPWpGaD
Sertraline—MAOA—Metabolism—CYP19A1—uterine cancer	3.63e-06	0.000769	CbGpPWpGaD
Sertraline—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—uterine cancer	3.6e-06	0.000762	CbGpPWpGaD
Sertraline—CYP2D6—Metabolism—STAR—uterine cancer	3.59e-06	0.00076	CbGpPWpGaD
Sertraline—CYP2D6—Metabolism—AKR1B1—uterine cancer	3.59e-06	0.00076	CbGpPWpGaD
Sertraline—CYP2C9—Metabolism—AKR1B1—uterine cancer	3.56e-06	0.000754	CbGpPWpGaD
Sertraline—CYP2C9—Metabolism—STAR—uterine cancer	3.56e-06	0.000754	CbGpPWpGaD
Sertraline—CYP2C9—Metabolism of lipids and lipoproteins—CYP19A1—uterine cancer	3.52e-06	0.000745	CbGpPWpGaD
Sertraline—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—uterine cancer	3.4e-06	0.000721	CbGpPWpGaD
Sertraline—CYP2B6—Metabolism—RRM2—uterine cancer	3.38e-06	0.000716	CbGpPWpGaD
Sertraline—CYP2B6—Metabolism—DCN—uterine cancer	3.28e-06	0.000695	CbGpPWpGaD
Sertraline—CYP3A4—Metabolism—NDUFB11—uterine cancer	3.25e-06	0.000688	CbGpPWpGaD
Sertraline—CYP3A4—Metabolism—SRD5A2—uterine cancer	3.25e-06	0.000688	CbGpPWpGaD
Sertraline—CYP2B6—Metabolism—CYP11A1—uterine cancer	3.09e-06	0.000655	CbGpPWpGaD
Sertraline—CYP2C19—Metabolism—POLD1—uterine cancer	3.06e-06	0.000649	CbGpPWpGaD
Sertraline—CYP1A2—Metabolism—STAR—uterine cancer	3.04e-06	0.000644	CbGpPWpGaD
Sertraline—CYP1A2—Metabolism—AKR1B1—uterine cancer	3.04e-06	0.000644	CbGpPWpGaD
Sertraline—CYP1A2—Metabolism of lipids and lipoproteins—CYP19A1—uterine cancer	3.01e-06	0.000637	CbGpPWpGaD
Sertraline—ABCB1—Metabolism—POLD1—uterine cancer	2.99e-06	0.000633	CbGpPWpGaD
Sertraline—CYP2B6—Metabolism—AKR1C3—uterine cancer	2.92e-06	0.000618	CbGpPWpGaD
Sertraline—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—uterine cancer	2.89e-06	0.000613	CbGpPWpGaD
Sertraline—CYP2C19—Metabolism—AKR1C1—uterine cancer	2.86e-06	0.000607	CbGpPWpGaD
Sertraline—CYP2D6—Metabolism—POLD1—uterine cancer	2.82e-06	0.000597	CbGpPWpGaD
Sertraline—ABCB1—Metabolism—AKR1C1—uterine cancer	2.8e-06	0.000592	CbGpPWpGaD
Sertraline—CYP2C9—Metabolism—POLD1—uterine cancer	2.79e-06	0.000592	CbGpPWpGaD
Sertraline—MAOA—Metabolism—MTHFR—uterine cancer	2.73e-06	0.000578	CbGpPWpGaD
Sertraline—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—uterine cancer	2.66e-06	0.000563	CbGpPWpGaD
Sertraline—CYP2D6—Metabolism—AKR1C1—uterine cancer	2.63e-06	0.000558	CbGpPWpGaD
Sertraline—CYP2C9—Metabolism—AKR1C1—uterine cancer	2.61e-06	0.000553	CbGpPWpGaD
Sertraline—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—uterine cancer	2.57e-06	0.000545	CbGpPWpGaD
Sertraline—CYP2C19—Metabolism—RRM2—uterine cancer	2.55e-06	0.000541	CbGpPWpGaD
Sertraline—ABCB1—Metabolism—RRM2—uterine cancer	2.49e-06	0.000528	CbGpPWpGaD
Sertraline—CYP2C19—Metabolism—DCN—uterine cancer	2.48e-06	0.000525	CbGpPWpGaD
Sertraline—ABCB1—Metabolism—DCN—uterine cancer	2.42e-06	0.000512	CbGpPWpGaD
Sertraline—MAOB—Metabolism—PTEN—uterine cancer	2.42e-06	0.000512	CbGpPWpGaD
Sertraline—CYP1A2—Metabolism—POLD1—uterine cancer	2.39e-06	0.000505	CbGpPWpGaD
Sertraline—CYP2D6—Metabolism—RRM2—uterine cancer	2.35e-06	0.000497	CbGpPWpGaD
Sertraline—CYP3A4—Metabolism—STAR—uterine cancer	2.35e-06	0.000497	CbGpPWpGaD
Sertraline—CYP3A4—Metabolism—AKR1B1—uterine cancer	2.35e-06	0.000497	CbGpPWpGaD
Sertraline—CYP2C19—Metabolism—CYP11A1—uterine cancer	2.34e-06	0.000495	CbGpPWpGaD
Sertraline—CYP2C9—Metabolism—RRM2—uterine cancer	2.33e-06	0.000493	CbGpPWpGaD
Sertraline—MAOB—Metabolism—EP300—uterine cancer	2.31e-06	0.000488	CbGpPWpGaD
Sertraline—CYP2D6—Metabolism—DCN—uterine cancer	2.28e-06	0.000483	CbGpPWpGaD
Sertraline—ABCB1—Metabolism—CYP11A1—uterine cancer	2.28e-06	0.000483	CbGpPWpGaD
Sertraline—CYP2B6—Metabolism—STK11—uterine cancer	2.27e-06	0.000482	CbGpPWpGaD
Sertraline—CYP2B6—Metabolism—CYP19A1—uterine cancer	2.27e-06	0.000482	CbGpPWpGaD
Sertraline—CYP2C9—Metabolism—DCN—uterine cancer	2.26e-06	0.000479	CbGpPWpGaD
Sertraline—CYP1A2—Metabolism—AKR1C1—uterine cancer	2.23e-06	0.000473	CbGpPWpGaD
Sertraline—CYP2C19—Metabolism—AKR1C3—uterine cancer	2.21e-06	0.000467	CbGpPWpGaD
Sertraline—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—uterine cancer	2.17e-06	0.00046	CbGpPWpGaD
Sertraline—ABCB1—Metabolism—AKR1C3—uterine cancer	2.15e-06	0.000456	CbGpPWpGaD
Sertraline—CYP2D6—Metabolism—CYP11A1—uterine cancer	2.15e-06	0.000455	CbGpPWpGaD
Sertraline—CYP2C9—Metabolism—CYP11A1—uterine cancer	2.13e-06	0.000451	CbGpPWpGaD
Sertraline—CYP2D6—Metabolism—AKR1C3—uterine cancer	2.03e-06	0.00043	CbGpPWpGaD
Sertraline—CYP2C9—Metabolism—AKR1C3—uterine cancer	2.01e-06	0.000426	CbGpPWpGaD
Sertraline—CYP1A2—Metabolism—RRM2—uterine cancer	1.99e-06	0.000421	CbGpPWpGaD
Sertraline—CYP1A2—Metabolism—DCN—uterine cancer	1.93e-06	0.000409	CbGpPWpGaD
Sertraline—CYP3A4—Metabolism—POLD1—uterine cancer	1.84e-06	0.00039	CbGpPWpGaD
Sertraline—CYP1A2—Metabolism—CYP11A1—uterine cancer	1.82e-06	0.000385	CbGpPWpGaD
Sertraline—CYP3A4—Metabolism—AKR1C1—uterine cancer	1.72e-06	0.000365	CbGpPWpGaD
Sertraline—CYP1A2—Metabolism—AKR1C3—uterine cancer	1.72e-06	0.000364	CbGpPWpGaD
Sertraline—CYP2C19—Metabolism—STK11—uterine cancer	1.72e-06	0.000364	CbGpPWpGaD
Sertraline—CYP2C19—Metabolism—CYP19A1—uterine cancer	1.72e-06	0.000364	CbGpPWpGaD
Sertraline—CYP2B6—Metabolism—MTHFR—uterine cancer	1.71e-06	0.000362	CbGpPWpGaD
Sertraline—MAOB—Metabolism—PIK3CA—uterine cancer	1.71e-06	0.000361	CbGpPWpGaD
Sertraline—ABCB1—Metabolism—CYP19A1—uterine cancer	1.68e-06	0.000355	CbGpPWpGaD
Sertraline—ABCB1—Metabolism—STK11—uterine cancer	1.68e-06	0.000355	CbGpPWpGaD
Sertraline—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	1.61e-06	0.000342	CbGpPWpGaD
Sertraline—CYP2D6—Metabolism—STK11—uterine cancer	1.58e-06	0.000335	CbGpPWpGaD
Sertraline—CYP2D6—Metabolism—CYP19A1—uterine cancer	1.58e-06	0.000335	CbGpPWpGaD
Sertraline—CYP2C9—Metabolism—STK11—uterine cancer	1.57e-06	0.000332	CbGpPWpGaD
Sertraline—CYP2C9—Metabolism—CYP19A1—uterine cancer	1.57e-06	0.000332	CbGpPWpGaD
Sertraline—CYP2C19—Metabolism of lipids and lipoproteins—EP300—uterine cancer	1.54e-06	0.000326	CbGpPWpGaD
Sertraline—CYP3A4—Metabolism—RRM2—uterine cancer	1.54e-06	0.000325	CbGpPWpGaD
Sertraline—MAOA—Metabolism—PTEN—uterine cancer	1.52e-06	0.000321	CbGpPWpGaD
Sertraline—CYP3A4—Metabolism—DCN—uterine cancer	1.49e-06	0.000316	CbGpPWpGaD
Sertraline—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	1.47e-06	0.000311	CbGpPWpGaD
Sertraline—MAOA—Metabolism—EP300—uterine cancer	1.45e-06	0.000307	CbGpPWpGaD
Sertraline—CYP3A4—Metabolism—CYP11A1—uterine cancer	1.4e-06	0.000297	CbGpPWpGaD
Sertraline—CYP2C9—Metabolism of lipids and lipoproteins—EP300—uterine cancer	1.4e-06	0.000297	CbGpPWpGaD
Sertraline—MAOB—Metabolism—AKT1—uterine cancer	1.39e-06	0.000295	CbGpPWpGaD
Sertraline—CYP1A2—Metabolism—STK11—uterine cancer	1.34e-06	0.000284	CbGpPWpGaD
Sertraline—CYP1A2—Metabolism—CYP19A1—uterine cancer	1.34e-06	0.000284	CbGpPWpGaD
Sertraline—CYP3A4—Metabolism—AKR1C3—uterine cancer	1.33e-06	0.000281	CbGpPWpGaD
Sertraline—CYP2C19—Metabolism—MTHFR—uterine cancer	1.29e-06	0.000273	CbGpPWpGaD
Sertraline—ABCB1—Metabolism—MTHFR—uterine cancer	1.26e-06	0.000267	CbGpPWpGaD
Sertraline—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	1.26e-06	0.000266	CbGpPWpGaD
Sertraline—CYP1A2—Metabolism of lipids and lipoproteins—EP300—uterine cancer	1.2e-06	0.000254	CbGpPWpGaD
Sertraline—CYP2D6—Metabolism—MTHFR—uterine cancer	1.19e-06	0.000252	CbGpPWpGaD
Sertraline—CYP2C9—Metabolism—MTHFR—uterine cancer	1.18e-06	0.000249	CbGpPWpGaD
Sertraline—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	1.14e-06	0.000241	CbGpPWpGaD
Sertraline—MAOA—Metabolism—PIK3CA—uterine cancer	1.07e-06	0.000227	CbGpPWpGaD
Sertraline—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	1.04e-06	0.00022	CbGpPWpGaD
Sertraline—CYP3A4—Metabolism—STK11—uterine cancer	1.03e-06	0.000219	CbGpPWpGaD
Sertraline—CYP3A4—Metabolism—CYP19A1—uterine cancer	1.03e-06	0.000219	CbGpPWpGaD
Sertraline—CYP1A2—Metabolism—MTHFR—uterine cancer	1.01e-06	0.000213	CbGpPWpGaD
Sertraline—CYP2B6—Metabolism—PTEN—uterine cancer	9.5e-07	0.000201	CbGpPWpGaD
Sertraline—CYP2B6—Metabolism—EP300—uterine cancer	9.06e-07	0.000192	CbGpPWpGaD
Sertraline—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	8.87e-07	0.000188	CbGpPWpGaD
Sertraline—MAOA—Metabolism—AKT1—uterine cancer	8.75e-07	0.000185	CbGpPWpGaD
Sertraline—CYP3A4—Metabolism—MTHFR—uterine cancer	7.76e-07	0.000164	CbGpPWpGaD
Sertraline—CYP2C19—Metabolism—PTEN—uterine cancer	7.18e-07	0.000152	CbGpPWpGaD
Sertraline—ABCB1—Metabolism—PTEN—uterine cancer	7.01e-07	0.000148	CbGpPWpGaD
Sertraline—CYP2C19—Metabolism—EP300—uterine cancer	6.85e-07	0.000145	CbGpPWpGaD
Sertraline—CYP2B6—Metabolism—PIK3CA—uterine cancer	6.71e-07	0.000142	CbGpPWpGaD
Sertraline—ABCB1—Metabolism—EP300—uterine cancer	6.69e-07	0.000142	CbGpPWpGaD
Sertraline—CYP2D6—Metabolism—PTEN—uterine cancer	6.61e-07	0.00014	CbGpPWpGaD
Sertraline—CYP2C9—Metabolism—PTEN—uterine cancer	6.55e-07	0.000139	CbGpPWpGaD
Sertraline—CYP2D6—Metabolism—EP300—uterine cancer	6.3e-07	0.000133	CbGpPWpGaD
Sertraline—CYP2C9—Metabolism—EP300—uterine cancer	6.25e-07	0.000132	CbGpPWpGaD
Sertraline—CYP1A2—Metabolism—PTEN—uterine cancer	5.6e-07	0.000119	CbGpPWpGaD
Sertraline—CYP2B6—Metabolism—AKT1—uterine cancer	5.48e-07	0.000116	CbGpPWpGaD
Sertraline—CYP1A2—Metabolism—EP300—uterine cancer	5.34e-07	0.000113	CbGpPWpGaD
Sertraline—CYP2C19—Metabolism—PIK3CA—uterine cancer	5.07e-07	0.000107	CbGpPWpGaD
Sertraline—ABCB1—Metabolism—PIK3CA—uterine cancer	4.95e-07	0.000105	CbGpPWpGaD
Sertraline—CYP2D6—Metabolism—PIK3CA—uterine cancer	4.66e-07	9.87e-05	CbGpPWpGaD
Sertraline—CYP2C9—Metabolism—PIK3CA—uterine cancer	4.62e-07	9.79e-05	CbGpPWpGaD
Sertraline—CYP3A4—Metabolism—PTEN—uterine cancer	4.32e-07	9.15e-05	CbGpPWpGaD
Sertraline—CYP2C19—Metabolism—AKT1—uterine cancer	4.14e-07	8.77e-05	CbGpPWpGaD
Sertraline—CYP3A4—Metabolism—EP300—uterine cancer	4.12e-07	8.72e-05	CbGpPWpGaD
Sertraline—ABCB1—Metabolism—AKT1—uterine cancer	4.04e-07	8.56e-05	CbGpPWpGaD
Sertraline—CYP1A2—Metabolism—PIK3CA—uterine cancer	3.95e-07	8.36e-05	CbGpPWpGaD
Sertraline—CYP2D6—Metabolism—AKT1—uterine cancer	3.81e-07	8.06e-05	CbGpPWpGaD
Sertraline—CYP2C9—Metabolism—AKT1—uterine cancer	3.77e-07	7.99e-05	CbGpPWpGaD
Sertraline—CYP1A2—Metabolism—AKT1—uterine cancer	3.23e-07	6.83e-05	CbGpPWpGaD
Sertraline—CYP3A4—Metabolism—PIK3CA—uterine cancer	3.05e-07	6.45e-05	CbGpPWpGaD
Sertraline—CYP3A4—Metabolism—AKT1—uterine cancer	2.49e-07	5.27e-05	CbGpPWpGaD
